SPLITOAK STRATEGIES LLC

Lobbying for CSL BEHRING LLC · Biotherapeutics company providing recombinant, plasma-derived and cell and gene products.

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · Pennsylvania · House · Senate · $40,000.00 income · posted Oct 20, 2025

Bills named in this filing 2

Lobbying activity 2

Health Issues

Issues related to plasma-derived therapies in rare diseases and critical care settings

Medicare/Medicaid

H.R.1476/S.694, PLASMA Act

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.